Cognition Therapeutics's total assets for Q4 2024 were $30.23M, an increase of 9.63% from the previous quarter. CGTX total liabilities were $11.48M for the fiscal quarter, a -12.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.